Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 13 November 2009, doi:10.1136/bmj.b4273
Cite this as: BMJ 2009;339:b4273
Andrea Tarr, associate editor, Ike Iheanacho, editor
1 Drug and Therapeutics Bulletin, BMJ Group, London WC1H 9JR
Correspondence to: I Iheanacho iiheanacho@bmjgroup.com
| The first 150 words of the full text of this article appear below. |
Regular topical application of an emollient cream or ointment is key in the management of patients with atopic eczema and is thought to help the skin maintain a defensive barrier effect, which is defective in atopic eczema.1 Support for such treatment comes from one (non-blinded) randomised controlled trial, which found that regular application of emollients direct to the skin reduced the amount of topical corticosteroid cream needed for atopic eczema in infants.2 Long clinical experience also suggests that directly applied emollients are safe and effective in atopic eczema.
People with atopic eczema are commonly also advised to use an emollient substitute for soap (such as aqueous cream or emulsifying ointment), as soap can irritate the skin (as can bubble bath preparations); patients are also often prescribed a bath emollient to add to their bath water.3 Bath emollients typically consist of liquid paraffin plus another emollient (usually wool fat or isopropyl
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?